Migraine pains are extremely hard to deal with, especially for people who have to suffer from them on a regular basis.
There are several medications that help dull the pain, however, most of them aren’t really completely effective in eradicating it.
Even if the pills do manage to take care of the pain, it still doesn’t take back the suffering the patients have to deal with while waiting for the pain to subside.
To take care of these issues, a device called the Cefaly was introduced in the market, which was the first FDA approved device for preventing the onset of migraines.
This devices uses the Transcutaneous Electrical Stimulation (TENS) treatment, and directs it at the trigeminal nerve, which is known to be directly involved with migraines and it’s accompanying pain.
The problem with that device however was the fact that it was too bulky and impractical to carry around with you on a daily basis.
So, in order to make the device more efficient and useful, the company behind the product has just launched the second generation of this product, known as the Cefaly II.
This new device is not only smaller in size, but also doesn’t rely on a headband to keep it up. Instead, it uses an adhesive electrode pad to attach to the forehead of the patient.
Once placed, all it takes is 20 minutes of therapy to prevent/reduce migraine headaches. The patients also have the option to increase the intensity of the stimulation, just in case the regular rhythm isn’t enough for them.
In addition to all these features, the Cefaly II also comes with a rechargeable battery, that can be charged via a standard USB port.
This was a direct response to the trouble many people faced, of having to carry spare AAA batteries just in case they have to use the device on the go.
As you can see, this device has certainly upgraded for the best. If you think you could make use of this device, then you’ll need a prescription from your doctor, before you can purchase it for $349.